Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Refining the Prothrombotic State in Atrial Fibrillation With Left Atrial Appendage Three-Dimensional Echocardiography.
Soulat-Dufour L, Lang S, Ponnaiah M, Simon T, Ederhy S, Adavane-Scheuble S, Chauvet-Droit M, Capderou E, Arnaud C, Sotto E, Cohen R, d'Izarny Gargas T, Scheuble A, Hammoudi N, Beraud AS, Addetia K, Boccara F, Lang RM, Cohen A. Soulat-Dufour L, et al. Among authors: hammoudi n. J Am Soc Echocardiogr. 2024 Nov 1:S0894-7317(24)00560-1. doi: 10.1016/j.echo.2024.10.014. Online ahead of print. J Am Soc Echocardiogr. 2024. PMID: 39489403 No abstract available.
Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature.
Rémond M, Pachev A, Battistella M, Gandon C, Mourah S, Madelaine I, Maggiori L, Benadon B, Hammoudi N, Lourenço N, Aparicio T. Rémond M, et al. Among authors: hammoudi n. Ther Adv Med Oncol. 2024 Sep 17;16:17588359241280541. doi: 10.1177/17588359241280541. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39314916 Free PMC article.
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.
Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, Čelutkienė J, Zdravkovic M, Bielecka-Dabrowa AM, Agostoni P, Xuereb RG, Neronova KV, Lelonek M, Cavusoglu Y, Gellen B, Abdelhamid M, Hammoudi N, Anker SD, Chioncel O, Filippatos G, Lainscak M, McDonagh TA, Mebazaa A, Piepoli M, Ruschitzka F, Seferović PM, Savarese G, Metra M, Rosano GMC, Maggioni AP; ESC EORP HF III National Leaders and Investigators. Lund LH, et al. Among authors: hammoudi n. Eur J Heart Fail. 2024 Dec;26(12):2487-2501. doi: 10.1002/ejhf.3445. Epub 2024 Sep 10. Eur J Heart Fail. 2024. PMID: 39257278 Free PMC article.
Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.
Hauguel-Moreau M, Guedeney P, Dauphin C, Auffret V, Clerc JM, Marijon E, Elbaz M, Aldebert P, Beygui F, Abi Khalil W, Da Costa A, Macia JC, Elhadad S, Cayla G, Iriart X, Laredo M, Rolland T, Temmar Y, Gheorghiu ME, Brugier D, Silvain J, Hammoudi N, Duthoit G, Diallo A, Vicaut E, Montalescot G; ACTION Study Group. Hauguel-Moreau M, et al. Among authors: hammoudi n. Circulation. 2024 Nov 19;150(21):1659-1668. doi: 10.1161/CIRCULATIONAHA.124.071186. Epub 2024 Sep 2. Circulation. 2024. PMID: 39222035 Clinical Trial.
Beta-Blocker Interruption or Continuation after Myocardial Infarction.
Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, Guedeney P, Cuisset T, Ivanes F, Lhermusier T, Petroni T, Lemesle G, Bresoles F, Labeque JN, Pommier T, Dillinger JG, Leclercq F, Boccara F, Lim P, Besseyre des Horts T, Fourme T, Jourda F, Furber A, Lattuca B, Redjimi N, Thuaire C, Deharo P, Procopi N, Dumaine R, Slama M, Payot L, El Kasty M, Aacha K, Diallo A, Vicaut E, Montalescot G; ABYSS Investigators of the ACTION Study Group. Silvain J, et al. N Engl J Med. 2024 Oct 10;391(14):1277-1286. doi: 10.1056/NEJMoa2404204. Epub 2024 Aug 30. N Engl J Med. 2024. PMID: 39213187 Clinical Trial.
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study.
Levy D, Saura O, Passarelli MT, Lucenteforte M, Lebreton G, Bougle A, Monsel A, Ortuno S, Benitha Y, Hammoudi N, Assouline B, Petit M, Gautier M, Le Fevre L, Pineton de Chambrun M, Juvin C, Chommeloux J, Luyt CE, Hékimian G, Leprince P, Combes A, Schmidt M. Levy D, et al. Among authors: hammoudi n. Intensive Care Med. 2024 Aug;50(8):1287-1297. doi: 10.1007/s00134-024-07501-9. Epub 2024 Jun 24. Intensive Care Med. 2024. PMID: 38913095
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease.
Bak MTJ, Demers K, Hammoudi N, Allez M, Silverberg MS, Fuhler GM, Parikh K, Pierik MJ, Stassen LPS, van der Woude CJ, Doukas M, van Ruler O, de Vries AC. Bak MTJ, et al. Among authors: hammoudi n. Aliment Pharmacol Ther. 2024 Aug;60(3):310-326. doi: 10.1111/apt.18040. Epub 2024 Jun 17. Aliment Pharmacol Ther. 2024. PMID: 38887827 Review.
186 results